The US Court of Appeals held that a non-resident foreign national cannot be guilty of violating the US Foreign Corrupt Practices Act as an accomplice or a co-conspirator if that person was incapable of committing it as a principal.
We provide an overview of the Transparency International annual CPI in relation to Asia Pacific countries focusing on the progress of China.
China has launched the “two-invoice” system in drug distribution on a trial basis, aiming to improve transparency in drug prices and eliminate excessive profit margins associated with multi-tier distribution models.